Month: February 2024

The Alabama Supreme Court’s recent decision that frozen embryos are “extrauterine children” will have far-reaching implications in the state and beyond, said an expert on family law and reproductive justice at Washington University in St. Louis.

Washington University School of Medicine in St. Louis is one of seven U.S. institutions joining a new national clinical trials network launched by the National Cancer Institute, part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths.

Washington University in St. Louis sophomore Da’Juantay Wynter has been selected by the Institute for Responsible Citizenship for its Washington Program, a selective, two-summer program for talented Black male college students.

New research by Hannah Birnbaum at Olin Business School finds that one reason why more people in advantaged groups — particularly men and white people — do not engage in acts of allyship is because they underestimate how their actions will be appreciated by members of disadvantaged groups.

A new study by Margot Moinester in Arts & Sciences is among the first to find positive health benefits associated with inclusive immigration policies — a sharp contrast to the harmful effects of restrictive policies.

Justin B. Serugo, a senior research technician in the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, died Feb. 6, 2024, in St. Louis following a battle with liver cancer. He was 44.

Neurologist Yo-El Ju, MD, a physician-scientist whose discoveries have illuminated the complex relationship between sleep and neurodegenerative disease, has been named an inaugural Barbara Burton and Reuben M. Morriss III Professor at Washington University School of Medicine in St. Louis.

Three early-career scientists at the School of Medicine have been honored with the Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI). They are Tarin M. Bigley, MD, PhD; Jeffrey W. Brown MD, PhD; and Drew J. Schwartz, MD, PhD.

State tobacco control programs that used a new training model were better able to sustain operations, finds a new study from the Brown School at Washington University in St. Louis.

GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.